Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 4/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.35 |
| ▸ | CTSC | P53634 | 4/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.30 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CTSH | P09668 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3367991 | 0.78 | OR51E2 (0.31) | — | |
| SCHEMBL2147382 | 0.72 | CA2 (0.35) | SLC1A2SLC1A3SLC1A1 | |
| SCHEMBL23482770 | 0.72 | — | — | |
| SCHEMBL28654671 | 0.69 | ALDH1A1 (0.33) | SLC1A2SLC1A3SLC1A1 | |
| SCHEMBL5286648 | 0.69 | SLC1A2 (0.42) | SLC1A2SLC1A3SLC1A1SLC7A5 | |
| SCHEMBL6070933 | 0.68 | — | — | |
| SCHEMBL7108725 | 0.68 | — | — | |
| SCHEMBL4364921 | 0.68 | CHRM1 (0.32) | SLC1A2SLC1A3SLC1A1CYP1A2 | |
| SCHEMBL28395438 | 0.67 | SLC1A2 (0.52) | SLC1A2SLC1A3SLC1A1CTSCSLC7A5 | |
| SCHEMBL25660318 | 0.67 | SLC1A2 (0.41) | SLC1A2SLC1A3SLC1A1CTSCSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851411-B2 | Herbicides; plant safening agents | BASF SE (DE) | 2010-12-14 | — | — | US | disclosed |
| EP-1458675-B1 | ALPHA-CYANOACRYLATES | BASF SE (DE) | 2010-02-24 | — | — | EP | disclosed |
| US-20050009706-A1 | Alpha-cyanoacrylates | BASF SE (DE) | 2005-01-13 | — | — | US | disclosed |
| EP-1458675-A1 | ALPHA-CYANOACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003051824-A1 | α-CYANOACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009706-A1 | Alpha-cyanoacrylates | CBR1, CBR3, CROCC | SLC1A2 2767/4885SLC1A3 2808/4885SLC1A1 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.